Description
MK-3697 is a selective orexin 2 receptor antagonist.
| Product Unit Size | Cost | Quantity | Stock |
|---|
MK-3697 is a selective orexin 2 receptor antagonist.
| Cas No. | 1224846-01-8 |
|---|---|
| Purity | ≥98% |
| Formula | C23H21N5O3S |
| Formula Wt. | 447.5 |
| Chemical Name | N-[(5,6-dimethoxypyridin-2-yl)methyl]-2-(5-methylpyridin-3-yl)-5-(1,3-thiazol-2-yl)pyridine-4-carboxamide |
| IUPAC Name | N-[(5,6-dimethoxypyridin-2-yl)methyl]-2-(5-methylpyridin-3-yl)-5-(1,3-thiazol-2-yl)pyridine-4-carboxamide |
| Synonym | MK3697; M8238285OA; (2,3'-Bipyridine)-4-carboxamide, N-((5,6-dimethoxy-2-pyridinyl)methyl)-5'-methyl-5-(2-thiazolyl)- |
| Solubility | Insoluble in water. DMSO (>20 mg/mL). |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Roecker AJ, Reger TS, Mattern MC. et.al. Discovery of MK-3697: a selective orexin 2 receptor antagonist (2-SORA) for the treatment of insomnia. Bioorg Med Chem Lett. (2014) 24:4884-90. PMID: 25248679 DOI: 10.1016/j.bmcl.2014.08.041.
Ornithine decarboxylase inhibitor.
TRPA1 antagonist
Cyclic depsipeptide is a secondary metabolite i...
Nonoxynol surfactant.
Electron carrier used to study dehydrogenase el...
Peptide, involved in neutrophil activation; FPR...
Allosteric inhibitor
MEK1 inhibitor.
Antimuscarinic
Calcineurin inhibitor, potential TRPV1 agonist....
VEGFR1/2/3, PDGFR, c-Kit, RET inhibitor.
AMPK activator, D1-4, 5-HT1A/2/3/6/7, M1-5 mACh...
GSK3 inhibitor.
Smo inhibitor.
Coumarin; VKORC1 inhibitor.
Nucleoside (guanosine) analog; DNA chain termin...
Endogenous peptide hormone, involved in enteric...
Synthetic glycyrrhetinic acid derivative; 11β-...
Mixture of pyrantel, a thiophene, and pamoic ac...
Abl inhibitor.